Skip to main content
. Author manuscript; available in PMC: 2012 Apr 5.
Published in final edited form as: Breast Cancer Res Treat. 2007 Oct 27;111(3):419–427. doi: 10.1007/s10549-007-9798-y

Fig. 4.

Fig. 4

Antitumor effect of PDTC in vitro and in vivo. (a) Decreasing SP fraction within MCF7 cells by PDTC. (b) Growth inhibition effect of PDTC, paclitaxel and combination on MCF7 sphere cells. (c) In vivo anti-tumor growth effect of PDTC (60 mg/kg) paclitaxel (10 mg/kg) and combination on MCF7 xenograft. Treatment was given twice a week for four weeks. Tumor sizes were measured twice weekly